Non-Hodgkin Lymphoma: Diagnosis and Treatment

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues

2017 • 12,167 citations

Cancer statistics, 2015

2015 • 11,660 citations

Cancer statistics, 2014

2014 • 11,270 citations

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

2000 • 9,712 citations

Cancer: Principles and Practice of Oncology.

1991 • 8,402 citations

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

2002 • 5,269 citations

World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues

2002 • 4,781 citations

A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

1993 • 4,650 citations

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

2014 • 4,380 citations

Revised Response Criteria for Malignant Lymphoma

2007 • 4,256 citations

Report of the Committee on Hodgkin's Disease Staging Classification.

1971 • 4,212 citations

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

2003 • 3,966 citations

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

2002 • 3,769 citations

A predictive model for aggressive non-Hodgkin's lymphoma

1993 • 3,483 citations

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

2014 • 3,320 citations

Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based Lymphomas

1995 • 2,833 citations

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1998 • 2,777 citations

Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

1995 • 2,428 citations

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

2002 • 2,400 citations

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

2006 • 1,992 citations

Helicobacter pylori Infection and Gastric Lymphoma

1994 • 1,845 citations

A Prognostic Score for Advanced Hodgkin's Disease

1998 • 1,694 citations

Follicular lymphoma international prognostic index.

2004 • 1,553 citations

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

2013 • 1,539 citations

Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

2005 • 1,454 citations

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

2012 • 1,429 citations

Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group

2014 • 1,429 citations

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

2004 • 1,395 citations

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

2013 • 1,338 citations

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

2006 • 1,336 citations

Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

2006 • 1,311 citations

Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas

2010 • 1,307 citations

Follicular lymphoma international prognostic index

2006 • 1,262 citations

Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD

1992 • 1,159 citations

Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

2003 • 1,080 citations

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

2002 • 1,076 citations

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

2008 • 1,072 citations

Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies

2012 • 1,069 citations

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1993 • 1,037 citations

Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia

2000 • 1,030 citations

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial

2010 • 1,010 citations

Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma

1998 • 1,010 citations

PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma

2014 • 1,001 citations

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

2004 • 971 citations

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

1998 • 967 citations

Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

2005 • 958 citations

The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas

1984 • 922 citations

Molecular Diagnosis of Burkitt's Lymphoma

2006 • 909 citations

Mechanisms of B-cell lymphoma pathogenesis

2005 • 902 citations

Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

2010 • 862 citations

Cancer Facts & Figures 2004

2004 • 853 citations

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma

2003 • 843 citations

Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma

1976 • 837 citations

Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease

2003 • 831 citations

Early Interim 2-[¹⁸F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study

2007 • 815 citations

High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

1987 • 797 citations

Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection

2002 • 797 citations

Annual Report to the Nation on the Status of Cancer (1973 Through 1998), Featuring Cancers With Recent Increasing Trends

2001 • 758 citations

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

2009 • 733 citations

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL

2004 • 722 citations

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma

2005 • 718 citations

¹³¹I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma

2005 • 716 citations

Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell Lymphoma

1991 • 712 citations

Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma

2015 • 692 citations

Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

2009 • 677 citations

MACOP-B Chemotherapy for the Treatment of Diffuse Large-Cell Lymphoma

1985 • 677 citations

Epidemiology of the non-Hodgkin’s lymphomas: Distributions of the major subtypes differ by geographic locations

1998 • 668 citations

Incidence of non-hodgkin lymphoma in kidney and heart transplant recipients

1993 • 664 citations

Double-hit B-cell lymphomas

2010 • 660 citations

Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

2012 • 627 citations

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

2012 • 606 citations

Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial

2006 • 595 citations

Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study

2011 • 594 citations

Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.

1997 • 584 citations

Whole-Body Positron Emission Tomography Using18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin’s Disease and Non-Hodgkin’s Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan Imaging

1999 • 561 citations

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

2014 • 559 citations

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network

2005 • 558 citations

Rearrangement ofMYCIs Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab

2010 • 546 citations

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

2010 • 544 citations

Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience

2000 • 541 citations

Evidence for an Association Between Chlamydia psittaci and Ocular Adnexal Lymphomas

2004 • 538 citations

Multiple Recurrent Genomic Defects in Follicular Lymphoma

1987 • 535 citations

Cancer Surveillance Series: Non-Hodgkin's Lymphoma Incidence by Histologic Subtype in the United States From 1978 Through 1995

2000 • 530 citations

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)

2003 • 529 citations

Epstein-Barr viral DNA in tissues of Hodgkin's disease.

1987 • 520 citations

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

2003 • 519 citations

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

2013 • 512 citations

Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed

2000 • 505 citations

T(14;18)(q32;q21) involving IGH andMALT1 is a frequent chromosomal aberration in MALT lymphoma

2003 • 498 citations

Treatment of Older Patients with Mantle-Cell Lymphoma

2012 • 495 citations

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

1997 • 494 citations

Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study

2009 • 488 citations

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL

2004 • 487 citations

High-Dose Therapy Improves Progression-Free Survival and Survival in Relapsed Follicular Non-Hodgkin’s Lymphoma: Results From the Randomized European CUP Trial

2003 • 484 citations

ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE

1975 • 483 citations

Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup Trial

2003 • 474 citations

Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma

2008 • 452 citations

Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study Group

2003 • 448 citations

Follicular lymphoma: prognostic factors for response and survival.

1986 • 444 citations

Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study

2000 • 441 citations

Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin’s Lymphoma

2002 • 430 citations

Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study Group

2002 • 428 citations

Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial

2010 • 416 citations

Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.

1996 • 404 citations

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

2011 • 403 citations

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

2002 • 395 citations

Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus

2006 • 391 citations

Response Assessment of Aggressive Non-Hodgkin’s Lymphoma by Integrated International Workshop Criteria and Fluorine-18–Fluorodeoxyglucose Positron Emission Tomography

2005 • 391 citations

ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma

2011 • 391 citations

Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

2003 • 388 citations

Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors

2013 • 384 citations

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.

1992 • 382 citations

New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

2005 • 376 citations

T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma

2005 • 364 citations

Clinical Presentation, Course, and Prognostic Factors in Lymphocyte-Predominant Hodgkin's Disease and Lymphocyte-Rich Classical Hodgkin's Disease: Report From the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease

1999 • 361 citations

Primary CNS Lymphoma

2006 • 360 citations

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.

1998 • 359 citations

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma

2003 • 358 citations

A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases

2005 • 354 citations

Mantle cell lymphoma

1998 • 353 citations

Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study

2014 • 352 citations

Chemotherapy With or Without Radiotherapy in Limited-Stage Diffuse Aggressive Non-Hodgkin's Lymphoma: Eastern Cooperative Oncology Group Study 1484

2004 • 350 citations

Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support

2004 • 348 citations

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial

2011 • 345 citations

Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial

2014 • 343 citations

Advanced Lymphosarcoma: Intensive Cyclical Combination Chemotherapy with Cyclophosphamide, Vincristine, and Prednisone

1972 • 341 citations

Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma

1993 • 340 citations

Concordance for Hodgkin's Disease in Identical Twins Suggesting Genetic Susceptibility to the Young-Adult Form of the Disease

1995 • 335 citations

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma

2003 • 333 citations

ABVD Plus Subtotal Nodal Versus Involved-Field Radiotherapy in Early-Stage Hodgkin's Disease: Long-Term Results

2004 • 333 citations

Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma

2010 • 332 citations

Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma

2009 • 327 citations

An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study

2002 • 326 citations

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

2003 • 326 citations

Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma

2013 • 323 citations

ACVBP versus CHOP plus Radiotherapy for Localized Aggressive Lymphoma

2005 • 322 citations

Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.

1997 • 310 citations

Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

2002 • 310 citations

Long-Term Follow-Up of Gastric MALT Lymphoma After Helicobacter Pylori Eradication

2005 • 305 citations

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

2012 • 304 citations

BCL2 Expression Is a Prognostic Marker for the Activated B-Cell–Like Type of Diffuse Large B-Cell Lymphoma

2006 • 297 citations

Safety of Yttrium-90 Ibritumomab Tiuxetan Radioimmunotherapy for Relapsed Low-Grade, Follicular, or Transformed Non-Hodgkin’s Lymphoma

2003 • 295 citations

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

2004 • 295 citations

Non-Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden

1997 • 293 citations

Comparison of CHOP Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-Hodgkin's Lymphoma

1995 • 289 citations

Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource

2013 • 287 citations

Risk Factors, Treatment, and Outcome of Central Nervous System Recurrence in Adults With Intermediate-Grade and Immunoblastic Lymphoma

1998 • 286 citations

Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3

2002 • 283 citations

Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)

2012 • 282 citations

Utility of Fine-Needle Aspiration As a Diagnostic Technique in Lymphoma

2004 • 275 citations

Maintenance Rituximab After Cyclophosphamide, Vincristine, and Prednisone Prolongs Progression-Free Survival in Advanced Indolent Lymphoma: Results of the Randomized Phase III ECOG1496 Study

2009 • 274 citations

ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial

2009 • 270 citations

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

2006 • 267 citations

Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987

1989 • 266 citations

Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study

2013 • 263 citations

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial

2008 • 263 citations

Mucosa-associated lymphoid tissue lymphoma.

1999 • 261 citations

Classification of natural killer (NK) cell and NK-like T-cell malignancies [editorial; comment]

1996 • 260 citations

Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma

2003 • 260 citations

t(11;18)(q21;q21) is the most common translocation in MALT lymphomas

1997 • 259 citations

Nordic <scp>MCL</scp>2 trial update: six‐year follow‐up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by <scp>BEAM</scp> or <scp>BEAC</scp> + autologous stem‐cell support: still very long survival but late relapses do occur

2012 • 258 citations

Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20⁺ Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

2012 • 258 citations

Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study

2012 • 256 citations

Helicobacter and gastric MALT lymphoma

2002 • 252 citations

Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study

2014 • 249 citations

Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial

2014 • 245 citations

Tositumomab and Iodine-131 Tositumomab Produces Durable Complete Remissions in a Subset of Heavily Pretreated Patients With Low-Grade and Transformed Non-Hodgkin’s Lymphomas

2005 • 242 citations

Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Advanced Chronic Lymphocytic Leukemia

2005 • 241 citations

Ten‐year follow‐up after intense chemoimmunotherapy with Rituximab‐HyperCVAD alternating with Rituximab‐high dose methotrexate/cytarabine (R‐MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma

2010 • 241 citations

Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

2006 • 239 citations

Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)

2012 • 238 citations

Gemcitabine in the Treatment of Refractory Hodgkin’s Disease: Results of a Multicenter Phase II Study

2000 • 234 citations

Stage I and II Follicular Non-Hodgkin’s Lymphoma: Long-Term Follow-Up of No Initial Therapy

2004 • 232 citations

Number of CD4⁺ Cells and Location of Forkhead Box Protein P3–Positive Cells in Diagnostic Follicular Lymphoma Tissue Microarrays Correlates With Outcome

2006 • 230 citations

Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.

1995 • 230 citations

T-cell non-Hodgkin lymphoma

2005 • 225 citations

Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.

1991 • 222 citations

1 The epidemiology of Hodgkin's disease

1996 • 215 citations

VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.

1998 • 214 citations

The Epstein–Barr virus and the pathogenesis of lymphoma

2014 • 213 citations

Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma

2002 • 212 citations

Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry

2011 • 211 citations

Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study

2008 • 208 citations

Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?

2004 • 208 citations

Therapy-Related Myelodysplasia and Secondary Acute Myelogenous Leukemia After High-Dose Therapy With Autologous Hematopoietic Progenitor-Cell Support for Lymphoid Malignancies

2000 • 208 citations

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.

1992 • 208 citations

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients

2000 • 208 citations

Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.

1995 • 203 citations

Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.

2001 • 202 citations

A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-hodgkin's lymphomas

2006 • 199 citations

Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial

2003 • 198 citations

The International Prognostic Index Correlates to Survival in Patients With Aggressive Lymphoma in Relapse: Analysis of the PARMA Trial

1998 • 198 citations

Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis

2013 • 197 citations

Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas.

1977 • 196 citations

Autotransplants for Hodgkin's Disease in Patients Never Achieving Remission: A Report From the Autologous Blood and Marrow Transplant Registry

1999 • 194 citations

The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation

1981 • 192 citations

High-Dose Therapy With Autologous Bone Marrow Support as Consolidation of Remission in Follicular Lymphoma: Long-Term Clinical and Molecular Follow-Up

2000 • 192 citations

A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma

2011 • 190 citations

Brief Chemotherapy and Involved Field Radiation Therapy for Limited-Stage, Histologically Aggressive Lymphoma

1987 • 189 citations

Hodgkin's Disease in Siblings

1977 • 184 citations

The role of positron emission tomography (PET) in the management of lymphoma patients

1999 • 184 citations

Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244

2009 • 180 citations

Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy

1994 • 177 citations

Interferon Alfa Combined with Cytotoxic Chemotherapy for Patients with Non-Hodgkin's Lymphoma

1992 • 176 citations

Rituximab Extended Schedule or Re-Treatment Trial for Low–Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402

2014 • 175 citations

Meta-Analysis to Evaluate the Role of Interferon in Follicular Lymphoma

2005 • 175 citations

Changing incidence of non‐Hodgkin lymphomas in the United States

2002 • 175 citations

Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.

1996 • 173 citations

Long-term results with radiotherapy for stage I–II follicular lymphomas

2001 • 172 citations

Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Münster) Multicenter Trial

2006 • 172 citations

Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions.

1986 • 168 citations

Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin’s disease: analysis of 280 patients from the French registry

1997 • 165 citations

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

1998 • 164 citations

Humanized Anti-CD20 Antibody, Veltuzumab, in Refractory/Recurrent Non-Hodgkin's Lymphoma: Phase I/II Results

2009 • 164 citations

Hodgkin’s Lymphoma: Biology and Treatment Strategies for Primary, Refractory, and Relapsed Disease

2003 • 162 citations

Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.

1997 • 160 citations

Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.

1978 • 158 citations

Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.

1988 • 156 citations

An autopsy study of histologic progression in non-Hodgkin's lymphomas 192 cases from the national cancer institute

1983 • 155 citations

Bi-weekly chlorambucil treatment of chronic lymphocytic leukemia

1974 • 155 citations

BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease

1997 • 153 citations

Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia.

1991 • 153 citations

Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma

2012 • 152 citations

Long-term outcome and mortality trends in early-stage, Grade 1–2 follicular lymphoma treated with radiation therapy

2005 • 149 citations

Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma.

1997 • 149 citations

Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.

1996 • 149 citations

Standard Chemotherapy With or Without High-Dose Chemotherapy for Aggressive Non-Hodgkin's Lymphoma: Randomized Phase III EORTC Study

2001 • 148 citations

Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group

2002 • 148 citations

Obinutuzumab (GA101) in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: Results From the Phase II GAUGUIN Study

2013 • 148 citations

Syngeneic Hematopoietic Stem-Cell Transplantation for Non-Hodgkin’s Lymphoma: A Comparison With Allogeneic and Autologous Transplantation—The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation

2003 • 148 citations

Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma

1979 • 148 citations

Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphoma

2002 • 147 citations

Randomized Study to Evaluate the Use of High-Dose Therapy as Part of Primary Treatment for “Aggressive” Lymphoma

2002 • 143 citations

Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect

2011 • 141 citations

Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up

1992 • 139 citations

Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non‐Hodgkin's lymphoma

2002 • 139 citations

High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.

1996 • 137 citations

Risk factors for Hodgkin’s disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents

2000 • 136 citations

Clinical significance of the WHO grades of follicular lymphoma in a population‐based cohort of 505 patients with long follow‐up times

2011 • 136 citations

Treatment of advanced non-Hodgkin's lymphomas with favorable histologies: preliminary results of a prospective trial

1976 • 135 citations

Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection

2007 • 134 citations

Early Autologous Stem-Cell Transplantation Versus Conventional Chemotherapy as Front-Line Therapy in High-Risk, Aggressive Non-Hodgkin’s Lymphoma: An Italian Multicenter Randomized Trial

2003 • 133 citations

Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma

2010 • 130 citations

Long-Term Follow-Up of Indolent Lymphoma Patients Treated With High-Dose Sequential Chemotherapy and Autografting: Evidence That Durable Molecular and Clinical Remission Frequently Can Be Attained Only in Follicular Subtypes

2004 • 130 citations

The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.

1990 • 128 citations

Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin.

2006 • 128 citations

Role of Nonmyeloablative Allogeneic Stem-Cell Transplantation After Failure of Autologous Transplantation in Patients With Lymphoproliferative Malignancies

2002 • 125 citations

Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000)

2013 • 123 citations

Assessment of the Stanford V Regimen and Consolidative Radiotherapy for Bulky and Advanced Hodgkin’s Disease: Eastern Cooperative Oncology Group Pilot Study E1492

2000 • 122 citations

Combination immunotherapy of relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma with rituximab and interferon-alpha-2a.

2000 • 120 citations

Watchful Waiting in Low–Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study Database

2012 • 119 citations

Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.

1995 • 112 citations

Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication ofHelicobacter pylori infection

2000 • 111 citations

High-Dose Therapy and Autologous Stem-Cell Transplantation Versus Conventional-Dose Consolidation/Maintenance Therapy as Postremission Therapy for Adult Patients With Lymphoblastic Lymphoma: Results of a Randomized Trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group

2001 • 110 citations

Correlation of chromosome abnormalities with histologic and immunologic characteristics in non-Hodgkin's lymphoma and adult T cell leukemia- lymphoma. Fifth International Workshop on Chromosomes in Leukemia- Lymphoma

1987 • 110 citations

Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma

2003 • 110 citations

Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms

1999 • 109 citations

Anaplastic Large Cell Lymphomas

2014 • 107 citations

Borrelia burgdorferi‐associated cutaneous marginal zone lymphoma: a clinicopathological study of two cases illustrating the temporal progression of B. burgdorferi‐associated B‐cell proliferation in the skin

2000 • 106 citations

Meta–analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics

2007 • 103 citations

Brief-Duration High-Intensity Chemotherapy for Patients With Small Noncleaved–Cell Lymphoma or FAB L3 Acute Lymphocytic Leukemia: Results of Cancer and Leukemia Group B Study 9251

2001 • 102 citations

CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma.

1999 • 101 citations

Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population

2006 • 99 citations

PET Scans in the Staging of Lymphoma: Current Status

2003 • 99 citations

Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma.

1985 • 99 citations

Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes

1987 • 98 citations

Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma

2010 • 97 citations

Hodgkin's disease during HIV1 infection: The French Registry Experience

1993 • 96 citations

Single‐agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a <scp>UK</scp> phase II study suggest activity and possible gender differences

2012 • 95 citations

Testicular lymphoma: improved outcome with early brief chemotherapy.

1988 • 94 citations

High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults

2008 • 93 citations

Favorable outcome of patients with relapsed or refractory Hodgkin’s disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dexa-BEAM)

1998 • 92 citations

Myelodysplastic syndrome after autologous transplantation for lymphoma: the price of progress [editorial]

1994 • 92 citations

T-Cell/Histiocyte-Rich B-Cell Lymphoma: Biology, Diagnosis, and Management

2006 • 87 citations

Combination sequential chemotherapy in advanced reticulum cell sarcoma

1972 • 86 citations

Patients with chemotherapy‐refractory mantle cell lymphoma experience high response rates and identical progression‐free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentre phase 2 clinical trial

2009 • 84 citations

Follicular lymphoma: Have we made any progress?

2000 • 84 citations

Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma

1995 • 83 citations

Primary Large-Cell Non-Hodgkin's Lymphoma of the Testis: A Retrospective Analysis of Patterns of Failure and Prognostic Factors

2001 • 81 citations

Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies.

1997 • 78 citations

Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysis

2011 • 78 citations

The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma

1999 • 71 citations

Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab

2013 • 67 citations

First Analysis of the Completed Mabthera International (Mint) Trial in Young Patients with Low-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Addition of Rituximab to a CHOP-Like Regimen Significantly Improves Outcome of All Patients with the Identification of a Very Favorable Subgroup with IPI=O and No Bulky Disease.

2004 • 65 citations

Hodgkin’s Disease

2005 • 62 citations

Pseudoautosomal Linkage of Hodgkin Disease

1999 • 60 citations

Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).

1999 • 59 citations

Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma

2003 • 57 citations

Six, Not Eight Cycles of Bi-Weekly CHOP with Rituximab (R-CHOP-14) Is the Preferred Treatment for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

2005 • 57 citations

Survival of patients with localized diffuse histiocytic lymphoma

1981 • 56 citations

Long‐term disease‐free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation

2004 • 54 citations

Long-Term Follow-Up Analysis of HD9601 Trial Comparing ABVD Versus Stanford V Versus MOPP/EBV/CAD in Patients With Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study From the Intergruppo Italiano Linfomi

2011 • 53 citations

β-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas

1993 • 52 citations

Non-Hodgkin's Lymphoma After Treatment of Hodgkin's Disease: Association with Epstein-Barr Virus

1986 • 51 citations

High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial.

2005 • 49 citations

Early-stage Hodgkin's disease: Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy

1994 • 47 citations

R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by autologous stem cell transplantation: CORAL study

2009 • 46 citations

Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage 111-IV patients

1997 • 43 citations

Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis

2014 • 43 citations

Genetics of Hodgkin's and Non-Hodgkin's Lymphoma: A Review

1992 • 40 citations

Anxiety and Health-Related Quality of Life Among Patients With Low–Tumor Burden Non-Hodgkin Lymphoma Randomly Assigned to Two Different Rituximab Dosing Regimens: Results From ECOG Trial E4402 (RESORT)

2015 • 39 citations

Interim Analysis of the Randomized Eortc/Lysa/Fil Intergroup H10 Trial On Early PET-Scan Driven Treatment Adaptation in Stage I/II Hodgkin Lymphoma

2012 • 39 citations

Vinorelbine: A New Promising Drug in Hodgkin's Disease

1996 • 39 citations

Newer treatments for non-Hodgkin's lymphoma: monoclonal antibodies.

1998 • 38 citations

Management of marginal zone lymphomas

2006 • 35 citations

Targeted Beacopp Variants In Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Interim Results Of a Randomized Phase II Study

2013 • 34 citations

Hodgkin's disease

2002 • 31 citations

A Randomized Phase III Trial of ABVD Vs. Stanford V +/− Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)

2010 • 29 citations

Allogeneic transplantation of hematopoietic stem cells after nonmyeloablative conditioning for Hodgkin’s disease: indications and results

2004 • 28 citations

Secondary Central Nervous System Lymphoma: Risk Factors and Prophylaxis

2005 • 28 citations

Richterʼs Syndrome

2005 • 26 citations

Cord Blood-Derived T Cells Can Be Genetically Engineered to Be B-Lineage All-Specific: Towards Adoptive Immunotherapy after Umbilical Cord Blood Transplantation.

2004 • 25 citations

No Role for Chemoradiotherapy When Compared with Chemotherapy Alone in Elderly Patients with Localized Low Risk Aggressive Lymphoma: Final Results of the LNH93-4 GELA Study.

2005 • 25 citations

Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, France.

1997 • 25 citations

Efficacy and toxicity of 2-chlorodeoxyadenosine (cladribine)—2h infusion for 5 days—as first-line treatment for advanced low grade non-Hodgkin’s lymphoma

1998 • 23 citations

Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial

2006 • 21 citations

Everolimus for Relapsed/Refractory Classical Hodgkin Lymphoma: Multicenter, Open-Label, Single-Arm, Phase 2 Study.

2012 • 20 citations

Randomized phase 3 study of rituximab, cyclophosphamide, doxorubicin, and prednisone plus vincristine (R-CHOP) or bortezomib (VR-CAP) in newly diagnosed mantle cell lymphoma (MCL) patients (pts) ineligible for bone marrow transplantation (BMT).

2014 • 15 citations

Diffuse Aggressive Histologies of Non-Hodgkin Lymphoma: Treatment and Biology of Limited Disease

2006 • 13 citations

Untitled

2000 • 13 citations

Untitled

1997 • 12 citations

Localized extranodal marginal zone B-cell lymphoma: clinical outcome with radiation therapy

2002 • 1 citations